Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Zhou, Zhi-Wei  [Clear All Filters]
2023
Zi D, Li Q, Xu C-X, Zhou Z-W, Bin Song G-, Bin Hu C-, Wen F, Yang H-L, Nie L, Zhao X, et al. Correction for: CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma. Aging (Albany NY). 2023;null.
2016
Pan S-T, Xue D, Li Z-L, Zhou Z-W, He Z-X, Yang Y, Yang T, Qiu J-X, Zhou S-F. Computational Identification of the Paralogs and Orthologs of Human Cytochrome P450 Superfamily and the Implication in Drug Discovery. Int J Mol Sci. 2016;17(7).
2015
Wang F, Li H, Yan X-G, Zhou Z-W, Yi Z-G, He Z-X, Pan S-T, Yang Y-X, Wang Z-Z, Zhang X, et al. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells. Drug Des Devel Ther. 2015;9:575-601.
Zhang L-F, Zhou Z-W, Wang Z-H, Du Y-H, He Z-X, Cao C, Zhou S-F. Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells. Drug Des Devel Ther. 2015;9:241-272.
Han X-D, Zhou Z-W, Yang W, Ye H-C, Xu Y-Z, Huang Y-F, Zhang T, Zhou S-F. A computational and functional study elicits the ameliorating effect of the Chinese herbal formula Huo Luo Xiao Ling Dan on experimental ischemia-induced myocardial injury in rats via inhibition of apoptosis. Drug Des Devel Ther. 2015;9:1063-102.
Zi D, Zhou Z-W, Yang Y-J, Huang L, Zhou Z-L, He S-M, He Z-X, Zhou S-F. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells. Int J Mol Sci. 2015;16(11):27228-27251.
Qiu J-X, Zhou Z-W, He Z-X, Zhang X, Zhou S-F, Zhu S. Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies. Drug Des Devel Ther. 2015;9:841-66.
He S, Zeng S, Zhou Z-W, He Z-X, Zhou S-F. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication. Drug Des Devel Ther. 2015;9:1103-75.
Zhou Z-W, Li X-X, He Z-X, Pan S-T, Yang Y, Zhang X, Chow K, Yang T, Qiu J-X, Zhou Q, et al. Induction of apoptosis and autophagy via sirtuin1- and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells. Drug Des Devel Ther. 2015;9:1511-1554.
Li J-P, Yang Y-X, Liu Q-L, Zhou Z-W, Pan S-T, He Z-X, Zhang X, Yang T, Pan S-Y, Duan W, et al. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells. Drug Des Devel Ther. 2015;9:1027-62.
Wang F, Wang Q, Zhou Z-W, Yu S-N, Pan S-T, He Z-X, Zhang X, Wang D, Yang Y-X, Yang T, et al. Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells. Drug Des Devel Ther. 2015;9:537-60.
Pan S-T, Qin Y, Zhou Z-W, He Z-X, Zhang X, Yang T, Yang Y-X, Wang D, Qiu J-X, Zhou S-F. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells. Drug Des Devel Ther. 2015;9:1601-1626.
Pan S-T, Zhou Z-W, He Z-X, Zhang X, Yang T, Yang Y-X, Wang D, Qiu J-X, Zhou S-F. Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach. Drug Des Devel Ther. 2015;9:937-68.
He J-L, Zhou Z-W, Yin J-J, He C-Q, Zhou S-F, Yu Y. Schisandra chinensis regulates drug metabolizing enzymes and drug transporters via activation of Nrf2-mediated signaling pathway. Drug Des Devel Ther. 2015;9:127-46.
Chen X-W, He Z-X, Zhou Z-W, Yang T, Zhang X, Yang Y-X, Duan W, Zhou S-F. An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus. Clin Exp Pharmacol Physiol. 2015.
2013
Chen S, Hou J-H, Feng X-Y, Zhang X-S, Zhou Z-W, Yun J-P, Chen Y-B, Cai M-Y. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma. J Surg Oncol. 2013.